A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Clinical trial NCT01468467 · COMPLETED

Trial details

NCT number: NCT01468467
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2012-04-01
Primary completion: 2015-03-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.